Target intelligence / Profile preview

Family with sequence similarity 83 member D (FAM83D)

Target
FAM83D
Molecular classification
Other (scaffolding protein, mitotic spindle-associated protein; not a receptor, enzyme, or transporter)
01

Overview

Family with sequence similarity 83 member D (FAM83D) is a mitosis-associated scaffolding protein localized to the mitotic spindle, where it recruits protein kinase CK1α to ensure proper spindle positioning and normal cell division[5]. FAM83D binds kinesins, microtubules, and protein kinases, modulating key aspects of the cell cycle, particularly chromosome alignment and G1/S transition[3][5]. Overexpression is found in numerous cancers and is linked to tumorigenesis, progression, and poor prognosis, making it a candidate diagnostic/prognostic biomarker[1]. FAM83D influences mitogenic signaling pathways, including ERK1/2 and possibly MTOR, JUN, and MYC signaling through its effects on protein stability[3][5]. There are currently no drugs targeting FAM83D directly, and it is not classified as a traditional receptor, enzyme, or transporter[1][3][5].

Other names
FAM83Dfamily with sequence similarity 83, member DHBV X protein-associated protein 5
02

Mechanism of action

Not applicable; no drugs are known to act directly on FAM83D.

03

Biological functions

Cell cycle regulation (e.g., mitosis, chromosome alignment, spindle positioning)Signal transduction (e.g., ERK1/2 pathway activation)Regulation of intracellular signal transduction
04

Disease associations

Cancer (e.g., overexpressed in various solid tumors; associated with poor prognosis in kidney, liver, lung, pancreas, and uterine cancers)Other: developmental disorders (Amelogenesis imperfecta type II, Filippi syndrome)
05

Safety considerations

Not applicable: No known safety or toxicity issues are reported for targeting FAM83D, since it is not a therapeutically targeted molecule
06

Interacting drugs

None reported. No current drugs are known to target FAM83D directly
07

Biomarkers

Prognostic/diagnostic biomarker in multiple cancers (e.g., overexpression predicts poor outcome in KIRC, LIHC, LUAD, PAAD, UCEC)

Beyond the preview

Go deeper on Family with sequence similarity 83 member D (FAM83D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 83 member D (FAM83D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call